Lu AE04621

· H. Lundbeck A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lu AE04621, covering 2019-12-02 to 2019-12-02. Get the full timeline:

Most recent: Clinical Trial Update: An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients [Phase 1]

See pricing